Darou Pakhsh Holding Company
TypePublic
TSE: DARO1
ISIN: IRO1DARO0008
IndustryPharmaceuticals, chemicals
Founded1956 (1956) (as Darou Pakhsh)
1997 (as Darou Pakhsh Holding)
HeadquartersTehran , Iran
Area served
Worldwide
ProductsVeterinary drugs, diagnostic imaging, general and specialty medicines, women's health products, over-the-counter drugs, diabetes care, pesticides, plant biotechnology
OwnerTPICO (74.5%)[1]
Websitewww.dpholding.com

Darou Pakhsh Holding Company (Persian: شرکت کارخانجات داروپخش, Shirkæt-e Karxanujat-e Darvipaxesh, lit. drug distribution company) is a major pharmaceutical company in Iran. The company is majority-owned by the Social Security Organization of Iran. The company manufactures, distributes, imports and exports finished products and pharmaceutical raw materials. Darou Pakhsh has an annual turnover of US$400m and claims to have the largest research and development operation of any Iranian drug firm.[2] The company formed a plasmapheresis joint venture with a German medical firm, Biotest AG, in early 2004.[2] Darou Pakhsh is listed on the Tehran Stock Exchange.

History

Initially, the plant had been designed to produce 20 dosage forms.

See also

References

  1. ↑ "Daroupakhsh ( DARO1 ) info". tsetmc.com. Retrieved 2012-05-26.
  2. 1 2 IRAN: Healthcare and Pharmaceuticals Forecast, Economist Intelligence Unit, August 18, 2008
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.